Pipeline
| Products | Clinical indication | Region |  | Licensee | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ripasudil hydrochloride hydrate | GLANATEC® | Glaucoma and ocular hypertension | Japan, Asia | ● | Kowa | ||||||
| K-321 | Fuchs endothelial corneal dystrophy | US, etc. | ● | Kowa | |||||||
| Ripasudil hydrochloride hydrate/ Brimonidine tartrate | GLA-ALPHA® | Glaucoma and ocular hypertension | Japan | ● | Kowa | ||||||
| DW-1002 | ILM staining | Europe, US, etc. | ● | DORC | |||||||
| ILM staining | Japan | ● | Wakamoto Pharmaceutical | ||||||||
| ALC staining | Japan | ● | |||||||||
| ILM, ERM and PVR membrane staining | Europe, etc. | ● | DORC | ||||||||
| ILM staining and ERM staining | US | ● | DORC | ||||||||
| DW-1001 | Ophthalmic treatment agent | Japan | ● | ROHTO Pharmaceutical | |||||||
| H-1337 | Glaucoma and ocular hypertension | US | ● | Developed internally | |||||||
| DW-5LBT | Neuropathic pain after shingles | US | ● | Jointly developed with MEDRx | |||||||
| DWR-2206 | Bullous Keratopathy | Japan | ● | Jointly developed with ActualEyes | |||||||
| Treatment for retinopathy of prematurity | Retinopathy of prematurity | Japan | ● | Developed by subsidiary JIT | |||||||
R&D Projects for new drug discovery
| Products | Clinical indication | Development process | Partner |
|---|---|---|---|
| Signal transduction inhibitor developing projects | Ophthalmology,Central Nervous System,Cardiovascular System,Respiratory System | Fundamental Research | Mie Univ. etc. |
| New device developing projects | Glaucoma,Corneal disorders,Retinal diseases | Fundamental Research | Glaukos |